z-logo
open-access-imgOpen Access
Sacituzumab govitecan — a new therapy for patients with triple-negative breast cancer
Author(s) -
Katarzyna Pogoda,
Agnieszka Jagiełło-Gruszfeld,
Aniwińska,
Zbigniew Nowecki
Publication year - 2023
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2022.0003
Subject(s) - medicine , triple negative breast cancer , irinotecan , oncology , breast cancer , chemotherapy , antibody drug conjugate , cancer , monoclonal antibody , immunology , antibody , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here